Abbvie cans Voyager Therapeutics gene Therapy investment

[Parkinsonjisung]

fiercebiotech.com/biotech/a...

[jimcaster]

That's disappointing.

[Parkinsonjisung in reply to jimcaster]

Ya, itd be interesting to know why as the data from their trials was promising

[felixned]

I bet they stopped because there's a growing experimental evidence that reducing ASNs is not doing much for PD

[Parkinsonjisung]

Just reading into this more. All the media reports are about their ASN antibody.

The research that I was aware of was this: cureparkinsons.org.uk/news/...

Which is more related to improving therapeutics rather going after ASN. It sounds completely different.

Am I misunderstanding?